EGFR and small cell lung carcinoma: El Zarif et al. showed that cfDNA epigenomic features, including histone post-translational modifications, DNA methylation, and chromatin accessibility, can distinguish transformed SCLC from EGFR-mutant lung adenocarcinoma with high accuracy, reflecting widespread epigenomic reprogramming associated with transformation [45].